Patents by Inventor Henry H. Mantsch

Henry H. Mantsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8060188
    Abstract: Prolonged and severe tissue hypoxia results in tissue necrosis in pedicled flaps. We demonstrate the potential of near-infrared spectroscopy for predicting viability of compromised tissue portions. This approach clearly identifies tissue regions with low oxygen supply, and also the severity of this challenge, in a rapid and non-invasive manner, with a high degree of reproducibility. Early, nonsubjective detection of poor tissue oxygenation following surgery increases the likelihood that intervention aimed at saving the tissue will be successful.
    Type: Grant
    Filed: February 24, 2009
    Date of Patent: November 15, 2011
    Assignee: National Research Council of CANADA
    Inventors: Miroslaw F. Stranc, Michael G. R. Sowa, Henry H. Mantsch
  • Patent number: 7860554
    Abstract: A non-invasive method of characterizing burn injuries using near infrared spectroscopy is described. In the method, a beam of light is emitted into the burnt tissue portion at two or more different tissue depths. The spectra are then compared using multivariate analysis to determine diagnostic regions of the spectra. This information is used to categorize the burn. In some cases, the diagnostic regions correspond to wavelengths related to the hemodynamics of the tissue portion. The spectra can also be repeated over time, thereby allowing trends and changes in the spectra to be measured. This data is in turn used to categorize the burn as either a superficial burn, partial thickness burn, deep partial burn or a full thickness burn. Once the burn has been categorized, the clinician can intervene as needed to treat the burn.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: December 28, 2010
    Assignee: National Research Council of Canada
    Inventors: Lorenzo Leonardi, Jerl Payette, Michael G. Sowa, Mark Hewko, Bernhard J. Schattka, Henry H. Mantsch
  • Patent number: 7729747
    Abstract: Prolonged and severe tissue hypoxia results in tissue necrosis in pedicled flaps. We demonstrate the potential of near-infrared spectroscopy for predicting viability of compromised tissue portions. This approach clearly identifies tissue regions with low oxygen supply, and also the severity of this challenge, in a rapid and non-invasive manner, with a high degree of reproducibility. Early, nonsubjective detection of poor tissue oxygenation following surgery increases the likelihood that intervention aimed at saving the tissue will be successful.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: June 1, 2010
    Inventors: Miroslaw F. Stranc, Michael G. Sowa, Henry H. Mantsch
  • Publication number: 20090216098
    Abstract: Prolonged and severe tissue hypoxia results in tissue necrosis in pedicled flaps. We demonstrate the potential of near-infrared spectroscopy for predicting viability of compromised tissue portions. This approach clearly identifies tissue regions with low oxygen supply, and also the severity of this challenge, in a rapid and non-invasive manner, with a high degree of reproducibility. Tissues remaining below a certain hemoglobin oxygen saturation threshold (oxygen saturation index <1) for prolonged periods (>6 h) became increasingly dehydrated, eventually becoming visibly necrotic. Tissues above this threshold (oxygen saturation index >1), despite being significantly hypoxic relative to the pre-elevation saturation values, remained viable over the 72 h post-elevation monitoring period. The magnitude of the drop in tissue oxygen saturation, as observed immediately following surgery, correlated with the final clinical outcome of the flap tissue.
    Type: Application
    Filed: February 24, 2009
    Publication date: August 27, 2009
    Inventors: Miroslaw F. Stranc, Michael G. R. Sowa, Henry H. Mantsch
  • Patent number: 7022527
    Abstract: A method of simultaneously determining the concentrations of cardiovascular risk markers selected from the group consisting of High Density Lipoprotein cholesterol (HDL-C), Low Density Lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides and oxidized LDL using infra-red and/or near infrared light is described.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: April 4, 2006
    Assignee: National Research Council of Canada
    Inventors: Kan-Zhi Liu, Anthony Shaw, Henry H. Mantsch
  • Publication number: 20040248309
    Abstract: A method of simultaneously determining the concentrations of cardiovascular risk markers selected from the group consisting of High Density Lipoprotein cholesterol (HDL-C), Low Density Lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides and oxidized LDL using infra-red and/or near infrared light is described
    Type: Application
    Filed: August 2, 2004
    Publication date: December 9, 2004
    Inventors: Kan-Zhi Liu, Anthony Shaw, Henry H. Mantsch
  • Publication number: 20040116814
    Abstract: Prolonged and severe tissue hypoxia results in tissue necrosis in pedicled flaps. We demonstrate the potential of near-infrared spectroscopy for predicting viability of compromised tissue portions. This approach clearly identifies tissue regions with low oxygen supply, and also the severity of this challenge, in a rapid and non-invasive manner, with a high degree of reproducibility. Tissues remaining below a certain hemoglobin oxygen saturation threshold (oxygen saturation index <1) for prolonged periods (>6 h) became increasingly dehydrated, eventually becoming visibly necrotic. Tissues above this threshold (oxygen saturation index >1), despite being significantly hypoxic relative to the pre-elevation saturation values, remained viable over the 72 h post-elevation monitoring period. The magnitude of the drop in tissue oxygen saturation, as observed immediately following surgery, correlated with the final clinical outcome of the flap tissue.
    Type: Application
    Filed: December 16, 2002
    Publication date: June 17, 2004
    Inventors: Miroslaw F. Stranc, Michael G. Sowa, Henry H. Mantsch
  • Patent number: 6587701
    Abstract: Prolonged and severe tissue hypoxia results in tissue necrosis in pedicled flaps. We demonstrate the potential of near-infrared spectroscopy for predicting viability of compromised tissue portions. This approach clearly identifies tissue regions with low oxygen supply, and also the severity of this challenge, in a rapid and non-invasive manner, with a high degree of reproducibility. Tissues remaining below a certain hemoglobin oxygen saturation threshold (oxygen saturation index<1) for prolonged periods (>6 h) became increasingly dehydrated, eventually becoming visibly necrotic. Tissues above this threshold (oxygen saturation index>1), despite being significantly hypoxic relative to the pre-elevation saturation values, remained viable over the 72 h post-elevation monitoring period. The magnitude of the drop in tissue oxygen saturation, as observed immediately following surgery, correlated with the final clinical outcome of the flap tissue.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: July 1, 2003
    Inventors: Miroslaw F. Stranc, Michael G. Sowa, Henry H. Mantsch
  • Patent number: 6424859
    Abstract: A novel near infrared spectroscopic technique was used to characterize the joints in arthritis with comparison against normal joints. A beam of near infrared light was passed to joints through a fibre optic cable. Scattered light was collected by the same fibre bundle and a spectrum of the joint computed. Multivariate pattern recognition techniques identified regions of the spectrum which allowed discrimination between healthy and affected joints. Linear discriminant analysis resulted in correct classification of 74% of the joints. The high degree of similarity between mean spectra representing the early, late and control groups along with the significant between—subject variability in the data make diagnosis based on visual assessment of the spectra impossible. Linear discriminant analysis was therefore applied to spectra to determine if spectra could be classified by statistical methods as arising from early or late RA. Application of LDA resulted in correct classification of 74% of the joints.
    Type: Grant
    Filed: June 17, 1999
    Date of Patent: July 23, 2002
    Inventors: Michael Jackson, Michael G. Sowa, James R. Mansfield, Hans H. Eysel, Henry H. Mantsch, Hani El-Gabalawy, Jan M. Canvin
  • Publication number: 20020007121
    Abstract: A novel near infrared spectroscopic technique was used to characterize the joints in arthritis with comparison against normal joints. A beam of near infrared light was passed to joints through a fiber optic cable. Scattered light was collected by the same fiber bundle and a spectrum of the joint computed. Multivariate pattern recognition techniques identified regions of the spectrum which allowed discrimination between healthy and affected joints. Linear discriminant analysis resulted in correct classification of 74% of the joints.
    Type: Application
    Filed: June 17, 1999
    Publication date: January 17, 2002
    Inventors: MICHAEL JACKSON, MICHAEL G. SOWA, JAMES R. MANSFIELD, HANS H. EYSEL, HENRY H. MANTSCH, HANI EL-GABALAWY, JAN M. CANVIN
  • Patent number: 5916152
    Abstract: A spectrophotometric analytical method for lung permeability is described. An exogenous polydispersed macromolecule is administered, and fluid of the patient is evaluated using infrared spectroscopy.
    Type: Grant
    Filed: May 15, 1997
    Date of Patent: June 29, 1999
    Assignees: Coretech Medical Technologies Corp., National Research Council of Canada
    Inventors: Luis Oppenheimer, Henry H. Mantsch, Michael G. Sowa, Jing Wang
  • Patent number: 5473160
    Abstract: Differences in the physical and chemical properties of synovial fluid from healthy and arthritic joints are detected by infrared spectroscopy. A beam of infrared light is directed at a sample of synovial fluid (either in its native form or prepared as a film) and changes in the physical and chemical properties of the fluid being analyzed are detected at one or more wavelengths to determine whether changes in the position, width, absolute intensity, relative intensity or shape of the infrared absorption have occurred which are characteristic of the arthritic condition.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: December 5, 1995
    Assignee: National Research Council of Canada
    Inventors: Hans H. Eysel, Michael Jackson, Henry H. Mantsch